B3 - Solving medication-related problems in a digital era

Auditorium 2

Organised by the FIP YPG in collaboration with FIP’s Community Pharmacy Section & Social and Administrative Pharmacy Section


Renly Lim, University of South Australia, Australia


The cost of medication-related problems has been estimated at USD $42 billion annually. The third WHO Global Patient Safety Challenge – Medication Without Harm – aims to reduce severe avoidable medication-related harm by 50% globally by 2022.

The frequency with which pharmacists have patient contact means pharmacists have significant potential to reduce the number of adverse medication events and medication-related hospital admissions. In addition, pharmacists are often the first health professional a patient sees after leaving hospital. This provides pharmacists the opportunity to proactively prevent and resolve medication-related problems post-discharge with medication reconciliation and review.

As the number of smartphone users continues to grow, more patients start tackling their own healthcare using smartphones. The wearable device market is also growing rapidly because the newer generations love smartwatches and activity trackers.

This session will focus on how pharmacists can reduce medication-related problems at different stages of patient care, using the collaborative power of digital technology.



  1. Digital tools to reduce adverse reactions in aged care facilities
    Libby Roughead, University of South Australia, Australia
  2. Interprofessional collaboration using patient-centered care through online platforms
    Agnes Gossenheimer, Rio Grande do Sul Federal University, Brazil
  3. Technological systems that may address and reduce interaction between drugs and improve medication adherence
    Kjell Halvorsen, Tromso University, Norway

Learning Objectives

At the end of this session, participants will be able to:

  1. Outline the digital health technologies available for pharmacists in various countries
  2. Describe the different digital tools currently trialled by pharmacists
  3. Identify digital technologies that be implemented in their local setting

Type of session: Knowledge-based